Clinicopathological Features and Prognostic Role of HER2 Low in Early Breast Cancer: A real world study

被引：0
作者：
Kong, Ziqing
Zhao, Weihong
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO2-02-07
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO2-02-07
引用
收藏
页数：3
相关论文
共 50 条
  • [21] HER2 as a prognostic factor in breast cancer
    Ménard, S
    Fortis, S
    Castiglioni, F
    Agresti, R
    Balsari, A
    [J]. ONCOLOGY, 2001, 61 : 67 - 72
  • [22] Clinicopathological features and prognostic significance of HER2-low status in breast carcinoma
    Ilieva-Shipchanova, N.
    Tashkova, D.
    Bangieva, E.
    Miteva, N.
    [J]. VIRCHOWS ARCHIV, 2024, 485 : S194 - S194
  • [23] Prognostic significance and evolution of HER2 zero, HER2 low and HER2 positive in breast cancer after neoadjuvant treatment
    Wei, T.
    Wang, D.
    Peng, Y.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S301 - S302
  • [24] Clinicopathological and prognostic features of HER2-null and HER2-low advanced breast cancer treated with eribulin or capecitabine
    Kitadai, Rui
    Shimoi, Tatsunori
    Yazaki, Shu
    Okuma, Hitomi Sumiyoshi
    Hoshino, Mai
    Ito, Munehiro
    Saito, Ayumi
    Kita, Shosuke
    Kojima, Yuki
    Nishikawa, Tadaaki
    Sudo, Kazuki
    Noguchi, Emi
    Fujiwara, Yasuhiro
    Yoshida, Masayuki
    Yonemori, Kan
    [J]. BREAST CANCER, 2024, 31 (06) : 1037 - 1045
  • [25] Analysis of clinicopathological characteristics and prognostic factors of early-stage human epidermal growth factor receptor 2 (HER2)-low breast cancer: Compared with HER2-0 breast cancer
    Wu, Qian
    Yang, Fan
    Liu, Yinhua
    Zhang, Hong
    Zhang, Shuang
    Xin, Ling
    Xu, Ling
    [J]. CANCER MEDICINE, 2023, 12 (19): : 19560 - 19575
  • [26] Can HER2 1+Breast Cancer Be Considered as HER2-Low Tumor? A Comparison of Clinicopathological Features, Quantitative HER2 mRNA Levels, and Prognosis among HER2-Negative Breast Cancer
    Shu, Lan
    Tong, Yiwei
    Li, Zhuoxuan
    Chen, Xiaosong
    Shen, Kunwei
    [J]. CANCERS, 2022, 14 (17)
  • [27] Prognostic factors in nonmetastatic HER2 'low' & HER2 'negative' breast cancer: Single institute experience
    Turkel, A.
    Dogan, M.
    Sertesen, E.
    Karacin, C.
    Irkkan, S. C.
    Ates, O.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S299 - S300
  • [28] Her2 low status and response to neoadjuvant chemotherapy in Her2 negative early breast cancer
    Mattos, Bruna RaphaeliSilva
    Cesca, Marcelle Goldner
    Leite, Luciana de Moura
    Tavares, Monique Celeste
    Silva, Sinara Figueiredo
    Pirolli, Rafaela
    Fogassa, Camilla AlbinaZanco
    Silva, Erick Figueiredo
    Rocha, Francisca Giselle
    Loose, Simone Klug
    Campos, Fernando AugustoBatista
    Sanches, Solange Moraes
    de Lima, Vladmir ClaudioCordeiro
    Ponde, Noam Falbel
    [J]. CANCER RESEARCH, 2021, 81 (04)
  • [29] Clinicopathological features and prognosis of patients with HER2-low breast cancer
    Xin Yang
    Yao Li
    Xu lu
    Xiaotian Ren
    Bin Hua
    [J]. BMC Cancer, 23 (1)
  • [30] Clinicopathological features and prognosis of patients with HER2-low breast cancer
    Yang, Xin
    Li, Yao
    Lu, Xu
    Ren, Xiaotian
    Hua, Bin
    [J]. BMC CANCER, 2023, 23 (01)
12345